PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

One in 3 intensive care survivors develop depression that manifests as physical symptoms

2014-04-07
(Press-News.org) A third of intensive care patients develop depression that typically manifests as physical, or somatic, symptoms such as weakness, appetite change, and fatigue, rather than psychological symptoms, according to one of the largest studies to investigate the mental health and functional outcomes of survivors of critical care, published in The Lancet Respiratory Medicine. The study suggests that intensive care unit (ICU) survivors could be three times more likely to experience depression than the general population, and that depression is four times more common than post-traumatic stress disorder (PTSD) after critical illness. "Considering that each year, at least 5 million individuals are admitted to ICU in North America alone—more than are diagnosed with cancer—and about 80% survive, it's a significant public health issue"*, explains study leader Dr James Jackson, psychologist and assistant professor of medicine at Vanderbilt University Medical Center in the USA. "We need to pay more attention to preventing and treating the physical rather than psychological symptoms of depression in ICU survivors," says Dr Jackson. "The physical symptoms of depression are often resistant to standard treatment with antidepressant drugs and we need to determine how best to enhance recovery with a new focus on physical and occupational rehabilitation."* The Bringing to Light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors (BRAIN-ICU) study prospectively observed 821 critically ill patients with respiratory failure or severe sepsis (blood poisoning) admitted to medical or surgical ICUs in Nashville, USA. The researchers used a battery of neuropsychological tests to assess survivors at 3 months (448 participants) and 12 months (382) for depression, PTSD, functional disability, and impact on quality of life. The researchers found that 149 of the 406 patients (37%) assessed at 3 months had at least mild depression—two-thirds due largely to physical rather than psychological symptoms. A third of the survivors who developed depression still had depressive symptoms at their 12 month assessment. While depressive symptoms were more likely to occur in patients with pre-existing depression, it was also found to be common in those without any psychiatric history, occurring in 76 of 255 patients (30%) at 3 months and 62 of 217 individuals (29%) at 12 months. In contrast, only 7% of patients experienced symptoms of PTSD.

The authors also noted that patients of all ages had high rates of disability in basic activities of daily living (eg, the inability to eat, bath, and dress without assistance)—32% at 3 months and 27% at 12 months. High rates of disability in instrumental activities of daily living (eg, the ability to manage money, make travel plans, make a complex shopping list, or follow a recipe) were also observed—26% at 3 months and 23% at 12 months. "These rates are worse than those seen in people with mild dementia"*, says Dr Jackson. According to Dr Jackson, "Substantial time and energy has been invested in addressing PTSD in survivors of critical illness, but our findings suggest that it is less pervasive than depression. Patients of all ages are at risk of developing post-ICU mental health and functional disabilities and more needs to be done to ensure that these impairments don't become permanent."* Commenting on the study, Hallie C Prescott from the University of Michigan and Theodore J Iwashyna from the Center for Clinical Management Research, VA Ann Arbor Health System in the USA write, "These findings have important implications. When depression manifests as physical symptoms, patients are less likely to receive a diagnosis. If they are diagnosed, they are less likely to respond to treatment…Traditional pharmacological therapies for depression might be less likely to provide significant benefit alone (or at all). Instead, doctors might need to address the many diagnoses that contribute to poor sleep, impaired concentration, weakness, and fatigue."

They add, "By differentiation of depression into cognitive and physical components, Jackson and colleagues have provided an important step towards tailoring of future interventions to specific symptoms subsets, and not the generic diagnosis of depression."

INFORMATION: NOTES TO EDITORS: *Quotes direct from author and cannot be found in text of Article.


ELSE PRESS RELEASES FROM THIS DATE:

Scaffolding protein promotes growth and metastases of epithelial ovarian cancer

2014-04-07
SAN DIEGO, CA (April 6, 2014)—Researchers from Fox Chase Cancer Center have shown that NEDD9, a scaffolding protein responsible for regulating signaling pathways in the cell, promotes the growth and spread of epithelial ovarian cancer. Previous studies have demonstrated the protein's importance in tumor invasion and spread of some lymphomas and many solid tumor types, including melanoma, neuroblastoma, and breast cancer, but its role in gynecological cancers has been poorly understood. The new data, to be presented on Sunday, April 6 at the AACR Annual Meeting 2014, ...

Non-invasive imaging instead of repeated biopsy in active monitoring of prostate cancer

2014-04-06
Your body's cells have two major interconnected energy sources: the lipid metabolism and the glucose metabolism. Most cancers feed themselves by metabolizing glucose, and thus can be seen in Positron Emission Topography (PET) scans that detect radiolabeled glucose. However, prostate cancers tend to use the lipid metabolism route and so cannot be imaged in this way effectively. A University of Colorado Cancer Center study being presented today at the American Association for Cancer Research (AACR) Annual Meeting 2014 describes a novel method to "manipulate the lipid metabolism ...

Researchers find that renal cancer cells thrive when put in the right environment and supported by a specific enzyme

2014-04-06
SAN DIEGO, CA (April 6, 2014)—Tumor cells are picky about where they live. In the wrong environment, they fail to reach their potential. But put those same cells on the right bit of real estate, and they grow like mad. Researchers at Fox Chase Cancer Center found renal cancer cells planted in a supportive environment proliferate with the help of an enzyme usually only seen in the brain. The enzyme, a specific isoform of a rather common kinase, may eventually become a target for cancer therapy as kinases constitute reasonably targetable enzymes, said Edna Cukierman, PhD, ...

Scripps Research Institute scientists provide new grasp of soft touch

Scripps Research Institute scientists provide new grasp of soft touch
2014-04-06
LA JOLLA, CA—April 6, 2014—A study led by scientists at The Scripps Research Institute (TSRI) has helped solve a long-standing mystery about the sense of touch. The "gentle touch" sensations that convey the stroke of a finger, the fine texture of something grasped and the light pressure of a breeze on the skin are brought to us by nerves that often terminate against special skin cells called Merkel cells. These skin cells' role in touch sensation has long been debated in the scientific community. The new study, however, suggests a dual-sensor system involving the Merkel ...

Amino acid fingerprints revealed in new study

Amino acid fingerprints revealed in new study
2014-04-06
VIDEO: This animation shows the basic process of sequencing amino acids in a nanopore, using the technique of recognition tunneling. Click here for more information. Some three billion base pairs make up the human genome—the floor plan of life. In 2003, the Human Genome Project announced the successful decryption of this code, a tour de force that continues to supply a stream of insights relevant to human health and disease. Nevertheless, the primary actors in virtually all ...

Scientists find potential drug targets in deadly pediatric brain tumors

Scientists find potential drug targets in deadly pediatric brain tumors
2014-04-06
BOSTON, MA (April 6, 2014) -- Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and McGill University. The findings identify potential new targets for drug treatments. The new research could help physicians choose targeted agents with a better chance of combating pediatric high-grade astrocytomas, which are extremely difficult to treat with radiation and surgery. The tumors have resisted ...

Field study shows why food quality will suffer with rising CO2

2014-04-06
For the first time, a field test has demonstrated that elevated levels of carbon dioxide inhibit plants' assimilation of nitrate into proteins, indicating that the nutritional quality of food crops is at risk as climate change intensifies. Findings from this wheat field-test study, led by a UC Davis plant scientist, will be reported online April 6 in the journal Nature Climate Change. "Food quality is declining under the rising levels of atmospheric carbon dioxide that we are experiencing," said lead author Arnold Bloom, a professor in the Department of Plant Sciences. "Several ...

Researchers find arid areas absorb unexpected amounts of atmospheric carbon

Researchers find arid areas absorb unexpected amounts of atmospheric carbon
2014-04-06
PULLMAN, Wash.—Researchers led by a Washington State University biologist have found that arid areas, among the biggest ecosystems on the planet, take up an unexpectedly large amount of carbon as levels of carbon dioxide increase in the atmosphere. The findings give scientists a better handle on the earth's carbon budget—how much carbon remains in the atmosphere as CO2, contributing to global warming, and how much gets stored in the land or ocean in other carbon-containing forms. "It has pointed out the importance of these arid ecosystems," said R. Dave Evans, a WSU professor ...

Friedreich's ataxia -- an effective gene therapy in an animal model

Friedreichs ataxia -- an effective gene therapy in an animal model
2014-04-06
The transfer, via a viral vector, of a normal copy of the gene deficient in patients, allowed to fully and very rapidly cure the heart disease in mice. These findings are published in Nature Medicine on 6 April, 2014. Friedreich's ataxia is a severe, rare hereditary disorder which combines progressive neuro-degeneration, impaired heart function and an increased risk of diabetes. The condition affects one in every 50,000 birth. There is currently no effective treatment for this disease. In most cases, Friedreich's ataxia starts in adolescence with impaired balance and ...

Smoking visibility mapped for the first time

Smoking visibility mapped for the first time
2014-04-06
The visibility of smoking in city streets has for the first time anywhere been mapped, in new research from the University of Otago, Wellington, New Zealand. The research found that up to 116 smokers outside bars/cafés could be seen from any one location in the outdoor public areas of downtown Wellington (e.g. on a footpath). Of 2600 people observed in the outdoor areas of bars and cafés, 16% were smoking, with a higher proportion than this in evenings. Data from observations across the downtown area were mapped by the researchers, producing a record of the street ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] One in 3 intensive care survivors develop depression that manifests as physical symptoms